hexahydrosiladifenidol has been researched along with Brain Neoplasms in 1 studies
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Reeve, HL | 1 |
| Vaughan, PF | 1 |
| Peers, C | 1 |
1 other study available for hexahydrosiladifenidol and Brain Neoplasms
| Article | Year |
|---|---|
Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptors.
Topics: Brain Neoplasms; Calcium Channel Blockers; GTP-Binding Proteins; Humans; Muscarine; Muscarinic Agoni | 1995 |